CARTI Research is currently working with pharmaceutical companies on over 35 clinical trials to bring advancement to oncology medicine. Clinical trials examine the safety and efficacy of new treatments, reduce the time between treatment and response evaluation, improve supportive care medications, monitor treatments in the real world setting and provide biological samples to develop tests for early cancer detection. Here at CARTI we are proud to offer front-line research to our patients. Our goal is to work toward innovation and improvement in standard of care. With a mission of providing the most leading-edge cancer care available, CARTIās medical team actively participates in research projects that will impact the treatment options we are able to provide our current and future patients.
WHAT RESEARCH IS PERFORMED AT CARTI?
TREATMENT TRIALS
Treating cancer with new drugs, devices or drug combinations.
Phase 1: How tolerable?
Phase 2: How effective?
Phase 3: Is it superior to standard of care?
BIOSPECIMEN TRIALS
Gathering blood, urine, tears, etc. from patients to look into important biomarkers or genetic factors that could help researchers better understand cancer and current treatments.
CANCER SCREENING TRIALS
Early cancer detection in an attempt to follow the patient through treatment and gather information about the disease.
OBSERVATIONAL TRIALS
Medical chart reviews that gather current healthcare information in a real world environment. Researchers can find important trends in health that could lead to ideas for future treatments.
Participation in research is always voluntary. For further information on clinical trials, please visit http://www.clinicaltrials.gov.
If you have any additional questions about CARTIās Research Department, please call 501.906.4199 or email Research@CARTI.com.